Antikaon angular distributions in the reaction γd→K−Θ+p→K−K+np{\gamma}d \to K^-{\Theta}^+p \to K^-K^+np near the threshold and the parity of the Θ+{\Theta}^+ pentaquark

Within spectator model we study the reaction ${\gamma}d \to K^-{\Theta}^+p \to K^-K^+np$ in the threshold energy region. We present the predictions for the exclusive and inclusive antikaon angular distributions in the laboratory system for this reaction calculated for two possible parity states of the ${\Theta}^+$ resonance at 1.5 and 1.75 GeV beam energies with and without imposing the relevant kinematical cuts on those parts of the sampled phase space where contribution from the main background sources associated with the ${\phi}(1020)$, ${\Lambda}(1520)$ production as well as with the $K^-p$--rescattering in the final state, is expected to be dominant. We show that under chosen kinematics these distributions are sensitive to the ${\Theta}^+$ parity and, therefore, can be used as a filter for the determination of its parity.Comment: 18 pages, 8 figures; will be published in Phys.Atom.Nucl_4_200

Neutrino spin rotation in dense matter and electromagnetic field

Exact solutions of the Dirac--Pauli equation for massive neutrino with anomalous magnetic moment interacting with dense matter and strong electromagnetic field are found. The complete system of neutrino wavefunctions, which show spin rotation properties are obtained and their possible applications are discussed.Comment: 11 pages, latex, misprints are correcte

SUSY CP phases and asymmetries at colliders

In the Minimal Supersymmetric Standard Model, physical phases of complex parameters lead to CP violation. We show how triple products of particle momenta or spins can be used to construct asymmetries, that allow us to probe these CP phases. To give specific examples, we discuss the production of neutralinos at the International Linear Collider. For the Large Hadron Collider, we discuss CP asymmetries in squark decays, and in the tri-lepton signal. We find that the CP asymmetries can be as large as 60%.Comment: 9 pages, 6 figures, To appear in the proceedings of DISCRETE'08: Symposium on Prospects in the Physics of Discrete Symmetries, Valencia, Spain, 11-16 Dec 200

The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study

Background: Immediate breast reconstruction (IBR) is routinely offered to improve quality-of-life for women requiring mastectomy, but there are concerns that more complex surgery may delay adjuvant oncological treatments and compromise long-term outcomes. High-quality evidence is lacking. The iBRA-2 study aimed to investigate the impact of IBR on time to adjuvant therapy. Methods: Consecutive women undergoing mastectomy ± IBR for breast cancer July–December, 2016 were included. Patient demographics, operative, oncological and complication data were collected. Time from last definitive cancer surgery to first adjuvant treatment for patients undergoing mastectomy ± IBR were compared and risk factors associated with delays explored. Results: A total of 2540 patients were recruited from 76 centres; 1008 (39.7%) underwent IBR (implant-only [n = 675, 26.6%]; pedicled flaps [n = 105,4.1%] and free-flaps [n = 228, 8.9%]). Complications requiring re-admission or re-operation were significantly more common in patients undergoing IBR than those receiving mastectomy. Adjuvant chemotherapy or radiotherapy was required by 1235 (48.6%) patients. No clinically significant differences were seen in time to adjuvant therapy between patient groups but major complications irrespective of surgery received were significantly associated with treatment delays. Conclusions: IBR does not result in clinically significant delays to adjuvant therapy, but post-operative complications are associated with treatment delays. Strategies to minimise complications, including careful patient selection, are required to improve outcomes for patients

Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018

BACKGROUND: Human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS) is still among the leading causes of disease burden and mortality in sub-Saharan Africa (SSA), and the world is not on track to meet targets set for ending the epidemic by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Sustainable Development Goals (SDGs). Precise HIV burden information is critical for effective geographic and epidemiological targeting of prevention and treatment interventions. Age- and sex-specific HIV prevalence estimates are widely available at the national level, and region-wide local estimates were recently published for adults overall. We add further dimensionality to previous analyses by estimating HIV prevalence at local scales, stratified into sex-specific 5-year age groups for adults ages 15-59 years across SSA. METHODS: We analyzed data from 91 seroprevalence surveys and sentinel surveillance among antenatal care clinic (ANC) attendees using model-based geostatistical methods to produce estimates of HIV prevalence across 43 countries in SSA, from years 2000 to 2018, at a 5 × 5-km resolution and presented among second administrative level (typically districts or counties) units. RESULTS: We found substantial variation in HIV prevalence across localities, ages, and sexes that have been masked in earlier analyses. Within-country variation in prevalence in 2018 was a median 3.5 times greater across ages and sexes, compared to for all adults combined. We note large within-district prevalence differences between age groups: for men, 50% of districts displayed at least a 14-fold difference between age groups with the highest and lowest prevalence, and at least a 9-fold difference for women. Prevalence trends also varied over time; between 2000 and 2018, 70% of all districts saw a reduction in prevalence greater than five percentage points in at least one sex and age group. Meanwhile, over 30% of all districts saw at least a five percentage point prevalence increase in one or more sex and age group. CONCLUSIONS: As the HIV epidemic persists and evolves in SSA, geographic and demographic shifts in prevention and treatment efforts are necessary. These estimates offer epidemiologically informative detail to better guide more targeted interventions, vital for combating HIV in SSA